Inventor
BIANCHI ELISABETTA
IT30 patents
⚠️ This page may combine multiple inventors who share the name “BIANCHI ELISABETTA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
10 patentsUS7928058B2Apr 19, 2011
Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition
MERCK SHARP & DOHME37 citations89
US10793615B2Oct 6, 2020
Long-acting co-agonists of the glucagon and GLP-1 receptors
MERCK SHARP & DOHME4 citations72
US10413593B2Sep 17, 2019
Co-agonists of the glucagon and GLP-1 receptors
MERCK SHARP & DOHME2 citations72
US10493125B2Dec 3, 2019
Co-agonists of the glucagon and GLP-1 receptors
MERCK SHARP & DOHME4 citations71
US9593155B2Mar 14, 2017
Oxyntomodulin analogs
MERCK SHARP & DOHME2 citations68
US11492385B2Nov 8, 2022
Long-acting co-agonists of the glucagon and GLP-1 receptors
MERCK SHARP & DOHME1 citations61
US7811577B2Oct 12, 2010
Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity
MERCK SHARP & DOHME5 citations59
US11566057B2Jan 31, 2023
Long-acting co-agonists of the glucagon and GLP-1 receptors
MERCK SHARP & DOHME0 citations51
US11306125B2Apr 19, 2022
PCSK9 antagonists bicyclo-compounds
MERCK SHARP & DOHME0 citations50
US10800826B2Oct 13, 2020
Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors
MERCK SHARP & DOHME0 citations47
MERCK SHARP & DOHME LLC
7 patentsUS11530244B2Dec 20, 2022
Cyclic polypeptides for PCSK9 inhibition
MERCK SHARP & DOHME LLC6 citations82
US11427616B2Aug 30, 2022
PCSK9 antagonist compounds
MERCK SHARP & DOHME LLC3 citations71
US11773150B2Oct 3, 2023
Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors
MERCK SHARP & DOHME LLC2 citations69
US12209145B2Jan 28, 2025
PCSK9 antagonist compounds
MERCK SHARP & DOHME LLC0 citations61
US11932705B2Mar 19, 2024
Cyclic polypeptides for PCSK9 inhibition
MERCK SHARP & DOHME LLC0 citations60
US12012468B2Jun 18, 2024
Cyclic polypeptides for PCSK9 inhibition
MERCK SHARP & DOHME LLC0 citations59
US11505575B2Nov 22, 2022
Cyclic polypeptides for PCSK9 inhibition
MERCK SHARP & DOHME LLC0 citations50
SANOFI SA
4 patentsUS10988524B2Apr 27, 2021
Modified relaxin B chain peptides and their therapeutic use
SANOFI SA2 citations70
US10961295B2Mar 30, 2021
Modified lipidated Relaxin B chain peptides and their therapeutic use
SANOFI SA2 citations69
US10988523B2Apr 27, 2021
Modified lipidated Relaxin B chain peptides and their therapeutic use
SANOFI SA2 citations68
US11725036B2Aug 15, 2023
Modified lipidated relaxin B chain peptides and their therapeutic use
SANOFI SA0 citations59